[Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].
Molins
A
A
Alvarez-Sabín
J
J
Montalbán
J
J
Molero
J
J
Alegre
J
J
Codina
A
A
D000287:Administration, Topical; D000368:Aged; D005260:Female; D005477:Fluprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*
C010958:9-fluoroprednisolone; D005477:Fluprednisolone
Miopatía hipopotasémica por administración tópica de 9 alfa flúor-prednisolona.